PuSH - Publication Server of Helmholtz Zentrum München

100 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
1.
Friemel, J.* et al.: Characterization of HCC Mouse Models: Towards an Etiology-Oriented Subtyping Approach. Mol. Cancer Res. 17, 1493-1502 (2019)
2.
Hess, J. et al.: A five-microRNA signature predicts survival and disease control of patients with head and neck cancer negative for HPV-infection. Clin. Cancer Res. 25, 1505-1516 (2019)
3.
Hess, J. et al.: A five-microRNA-signature predicts recurrence and survival in HPV-negative HNSCC. Strahlenther. Onkol. 195, S25-S25 (2019)
4.
Kleemann, M.* et al.: Induction of apoptosis in ovarian cancer cells by miR-493-3p directly targeting AKT2, STK38L, HMGA2, ETS1 and E2F5. Cell. Mol. Life Sci. 76, 539-559 (2019)
5.
Klymenko, O. et al.: Patient-derived HNSCC cell lines and subclones reflect inter- and intra-tumoral heterogeneity regarding genomic copy number alterations and radiation response. Strahlenther. Onkol. 195, S75-S76 (2019)
6.
Malehmir, M.* et al.: Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer. Nat. Med. 25, 641-655 (2019)
7.
Osterode, E.* et al.: Evaluation of CD44v6 targeting strategies in HNSCC. Strahlenther. Onkol. 195, S176-S176 (2019)
8.
Piehlmaier, D. et al.: In-vitro and in-vivo characterization of a glioblastoma cell line panel. Strahlenther. Onkol. 195, S63-S64 (2019)
9.
Saborowski, A.* et al.: Murine liver organoids as a genetically flexible system to study liver cancer in vivo and in vitro. Hepat. Commun. 3, 423-436 (2019)
10.
Schnoeller, L.* et al.: In-depth characterization of radiation response in a human glioblastoma cell line panel. Strahlenther. Onkol. 195, S120-S121 (2019)
11.
Spinell, T.* et al.: In-vitro cytocompatibility and growth factor content of GBR/GTR membranes. Dent. Mater. 35, 963-969 (2019)
12.
Unger, K. et al.: Validation of a 4-miRNA prognosticator allowing for improved risk stratification of glioblastoma patients in combination with MGMT promoter methylation status. Strahlenther. Onkol. 195, S63-S63 (2019)
13.
Weber, J.* et al.: PiggyBac transposon tools for recessive screening identify B-cell lymphoma drivers in mice. Nat. Commun. 10:1415 (2019)
14.
Wintergerst, L. et al.: A 16q24.3 4-gene mRNA signature predicts outcome in radio(chemo)therapy-treated head and neck squamous cell carcinoma. Strahlenther. Onkol. 195, S24-S25 (2019)
15.
Baumeister, P. et al.: High expression of EpCAM and Sox2 is a positive prognosticator of clinical outcome for head and neck carcinoma. Sci. Rep. 8:14582 (2018)
16.
Dalke, C. et al.: Lifetime study in mice after acute low-dose ionizing radiation: A multifactorial study with special focus on cataract risk. Radiat. Environ. Biophys. 57, 99-113 (2018)
17.
Kleemann, M.* et al.: MiR-744-5p inducing cell death by directly targeting HNRNPC and NFIX in ovarian cancer cells. Sci. Rep. 8:9020 (2018)
18.
Klymenko, O. et al.: HNSCC derived cell lines and subclones differ in genomic copy number changes and radiation response. Radiother. Oncol. 127, S1266-S1267 (2018)
19.
Mueller, S.* et al.: Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes. Nature 554, 62-68 (2018)
20.
Mueller, S.* et al.: Evolutionary trajectories and KRAS gene dosage define pancreatic cancer phenotypes. Cancer Res. 78 (2018)